Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] 2-06-2025, 12:00

Global Virus Network’s Annual Meeting Fortifies Bonds on the African Continent to Catalyze Innovative Research, Strengthen Pandemic Preparedness, and Combat Scientific Misinformation 18-09-2024, 22:15

Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor) 25-02-2026, 07:30